Synteract is a full-service, international CRO

Since 1987, we have been guiding virtual, emerging, and mid-sized biopharma companies across the spectrum of Phase I - IV clinical studies with support services that address their specific needs.

9/23/2018 - 9/26/2018 : SCDM 2018 More...

8/1/2018: Synteract project director Francoise Desir named as one of the PharmaVOICE 100 Most inspiring people in the life sciences industry 2018. More ...

8/24/2018: Get to Know Francoise Desir – Our 2018 PharmaVOICE 100 Recipient - We sat down with Francoise Desir, Senior Project Manager, to find out her thoughts about being named a PharmaVOICE 100 recipient, learn more about her experience with Synteract, and get to know her personally.

Synteract Blog 

9/18/2018: Together with Cu-Tech, we have conducted 230+ dermatology clinical trials across 20+ indications. Learn how we are creating the leading dermatology CRO: https://lnkd.in/gxcqRqw #dermatology #acne #skincancer #psoriasis #clinicaltrials

Synteract on LinkedIn

9/17/2018: At Synteract, we listen and collaborate to tailor a project plan that strategically adapts our services to support… https://t.co/jQI4mUpMXe

Synteract Twitter Feed
x

Contact Synteract

Tell us how to stay in touch with you:

*Required